Solar Industries India Ltd
NSE:SOLARINDS
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
6 341.9
12 362.15
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Earnings Call Analysis
Q2-2025 Analysis
Solar Industries India Ltd
Solar Industries India Limited showcased impressive performance in the second quarter of FY '25, with a remarkable 27% year-on-year revenue growth. The company's consolidated revenue reached INR 1,716 crores compared to INR 1,347 crores in Q2 of the previous year. Profit after tax (PAT) surged by 45% to INR 304 crores, attributed largely to the defense sector's robust contributions.
The earnings report highlighted record-breaking metrics, with EBITDA hitting INR 475 crores, reflecting a 38% increase from the previous year. Notably, this quarter exhibited an EBITDA margin of 27.7%, marking an improvement from 25.52%. Half-yearly figures also looked promising, with PAT rising to INR 604 crores against INR 411 crores, underscoring the strong operational performance.
The defense segment has become a significant driver for the company's growth, experiencing a staggering 204% increase in revenue year-on-year, reaching INR 322 crores in Q2 FY '25. The management expresses confidence in achieving annual defense product sales of approximately INR 1,500 crores, aiming for defense to constitute about 20% of total sales by year-end.
To support this expansion, Solar Industries is revising its capital expenditure (CapEx) guidance upwards from INR 800 crores to INR 1,200 crores for FY '25. This increment reflects the company's commitment to infrastructure development and product enhancement, including anticipated defense orders from both domestic and international clients.
The company currently has a strong order book exceeding INR 5,700 crores, encompassing defense contracts worth approximately INR 3,300 crores and INR 2,400 crores from Coal India and others. This order diversity positions Solar favorably for sustained revenue generation and profitability in the upcoming quarters.
Despite these achievements, Solar Industries faced headwinds from subdued domestic demand due to political elections and a heavy monsoon, which impacted the mining and infrastructure sectors. Nonetheless, the international business and defense sectors mitigated these challenges, showcasing resilience and adaptability.
The management expressed optimism about achieving net debt-free status by year-end, attributing this to incoming orders and advances. The company's focus on maintaining healthy financial ratios while facilitating growth bodes well for long-term investor value.
Looking forward, the management expects to sustain EBITDA margins above 25% over the next few years, which should reassure investors of the company's profitability trajectory. Additionally, the allocation of increased CapEx emphasizes the management's intent to capitalize on growth prospects in the defense and international sectors.
Ladies and gentlemen, good day, and welcome to Solar Industries Limited Q2 FY '25 Earnings Conference Call hosted by Nirmal Bang Institutional Equities.
[Operator Instructions]
Please note that this conference is being recorded.
I now hand the conference over to Ms. Natasha Jain from Nirmal Bang Institutional Equities. Thank you, and over to you, ma'am.
Thank you, Manav, and good morning, everyone. We welcome all of you to the Second Quarter FY '25 Earnings Conference Call of Solar Industries India Limited. Today on the call from the management, we have Mr. Manish Nuwal, MD and CEO; Mr. Suresh Menon, Executive Director; Mr. Milind Deshmukh, Executive Director; Mr. Moneesh Agrawal, joint CFO; Ms. Shalinee Mandhana, joint CFO; and Ms. Aanchal Kewlani, SRM and IRM.
I would now like to hand over the call to Aanchal. Thank you, and over to you, ma'am.
Thank you so much, Natasha. It's a pleasure to have you on the call. A very good morning to our dear stakeholders and well-wishers. My name is Aanchal, and I would like to welcome you all to the Solar Industries India Limited second quarter and half yearly conference call of FY '25. This call's recording, including the transcript, will be available on the site. The financial statements, quarterly fact sheets, investor presentation and press release are also available on our website.
To begin with, I would like to remind you that during the call, we might make projections of other forward-looking statements regarding future events and about the future financial performance. Please remember that such statements are only predictions. Actual events or results may differ materially. And our website will be updated with all relevant information timely.
Now I would request Solar's CEO and MD, Mr. Manishji Nuwal for his opening remarks on the company's performance followed by Q&A session. Thank you. Over to you, sir.
A very good morning to all the well-wishers and stakeholders of Solar. With much enthusiasm, I take this opportunity to highlight Solar's resilience and strategic agility. The second quarter of this year, once again, brings us the privilege of announcing record achievements across key metrics. We have delivered a robust performance by registering the growth of 27% year-on-year in this quarter.
We have achieved the highest ever quarterly EBITDA and profit after tax at INR 475 crores and INR 304 crores, registering a PAT growth of 45% year-on-year and highest ever half yearly EBITDA and PAT at INR 949 crores and INR 604 crores, registering a PAT growth of 47% in the first half of the year FY '25.
The company has also achieved highest ever quarterly -- highest ever yearly EBITDA and PAT margins at around 27.9% and 17.7%, respectively. The company's portfolio expansions and capacity products from energetic materials to ammunitions has received a strong support from India's defense contracts and export orders. We are expecting the Pinaka orders very soon, along with the orders from international customers.
We are glad to share that the defence section potential has started unfolding with the revenue growth of 204% year-on-year and increasing threefold from INR 106 crores to INR 322 crores in this quarter. We are optimistic of achieving defence product sales of INR 1,500 crores, with defence reaching around 20% of our total sales for the year FY '25. We remain confident in Solar Industries growth trajectory, which will continue to drive long-term value for our investors and stakeholders.
As we move forward, the government's ongoing commitment to housing and infrastructure development, along with the rising power demand gives us confidence to reach our annual guidance. Our industry has faced subdued demand due to elections and heavy monsoon season, impacting the execution of mining and infrastructure activities in the first half of the year. Despite these strong headwinds, we have achieved a growth due to robust performances from our international business and defence section.
We are happy to highlight that we have recently backed the 2-year order from Singareni Collieries to the tune of INR 887 crores and defence products worth INR 1,110 crores, consolidating our current order book to INR 5,700 crores plus. On the backdrop of these orders and upcoming opportunities, we are revising our annual CapEx guidance significantly upward from INR 800 crores to INR 1,200 crores for the year '25. The progress made by the company over the past 2.5 decades, with substantial contracts across defense, in distal explosives and export segment. Solar Industries has fortified 5 order books and laid a solid foundation for sustained growth.
Our development has been radical as we continue to explore growth opportunities. We remain committed to high performance culture, which will help the company to create value for the stakeholders.
Now I will hand over the call to Aanchal for the quarterly update. Thank you.
Thank you so much, sir. Before beginning, I would like to highlight on major quarter updates. Highest ever quarterly EBITDA at INR 475 crores and PAT at INR 304 crores. Highest ever quarterly defence revenue registered at INR 322 crores, highest ever order book crossing INR 5,700 crores, revised CapEx for FY '25 from INR 800 crores to INR 1,200 crores.
We have already shared the investor presentation, carrying all necessary information for your [indiscernible]. So we will go quickly through the numbers. The consolidated revenue for the quarter is INR 1,716 crores versus INR 1,347 crores and for half year, INR 3,401 crores versus INR 3,030 crores. Our explosive volume for the quarter and half yearly has increased by 7% and 12%, respectively. Initiating Systems revenue increased by 2% in the half year. The percentage of the sectors in the customer basket are as follows: CIL is down in the basket to 10% from 14%. Non-CIL & institutional is at 13% from 15%. H&I is at 11% in the basket. Exports and overseas is almost similar at 46% from 47%, and defence has increased and is at 19%, quite close to our annual guidance of reaching 20% from 8% in the basket in the previous year.
In the half year, the basket more or less remains the same, except for CIL, which has come down from 15% to 12% in defence, which is majorly increased from 9% to 15% in the basket. And in absolute terms, the same has increased by 98% year-on-year. Raw malarial consumption for the quarter stands at INR 843 crores versus INR 653 crores and for half year, it stands at INR 1,713 crores versus INR 16,15 crores.
Coming to employee costs, the employee cost for the quarter stands at INR 145 crores against INR 103 crores. And for half year, it is INR 276 crores against INR 203 crores. Other expenses for the quarter stand at INR 283 crores versus INR 255 crores in the quarter. And for half year, it stands at INR 518 crores.
Coming to EBITDA. We reported an EBITDA of INR 475 crores against INR 344 crores showing a decent rise in the margin from 25.52% to 27.70% in the seasonally weak quarter. We reported half yearly EBITDA of INR 949 crores against INR 675 crores with a margin of 27.90% against 22.29%. Interest and finance charges. The costs stand at INR 30 crores against INR 25 crores and for half yearly, the cost stands at INR 57 crores against INR 50 crores.
Depreciation cost stands at INR 44 crores against INR 34 crores. And for half yearly, it stand at INR 84 crores against INR 68 crores. PBT stands at INR 407 crores against INR 285 crores. And for the half year, it stands at INR 815 crores versus INR 557 crores.
For PAT, highest ever quarterly PAT stands at INR 304 crores, against INR 209 crores, with margin standing at 17.70% against 15.51%. For the half year, it stands at INR 604 crores against INR 411 crores with a margin of 17.77% against 13.55%. These were the updates for the quarter and half year consolidated.
This is all from our side. Now we would be happy to take any questions, comments or suggestions that you may have. Over to you, Natasha.
Yes. So Manav, can you please start the Q&A round.
[Operator Instructions]
We have our first question from the line of Bharat Shah from ASK Investments.
Remarkable results, congratulations to the team. Just 1 question. I was looking at last 3 to 4 years of the results quarter-by-quarter. And it's evident that what is the volume sold and trying to relate to the profits made or profitability in terms of the margin is easy or very directly correlated exercise. So therefore, I presume amount of -- or the quantity of the volume sold relatively has low correlation with the profits made.
Profits will be the function, I suppose, of the mix. So clearly, defence has gone up as a percentage. And that has a deep impact on the margins also, the highest ever margins in a quarter. Is that a correct way to judge? Because quantitative volumes sold have varied even in a high volume sold, profits have been lower in some quarters and low volume sold also the profits have been much higher. Therefore, I think the profits are more coordinated to the mix and the maybe the raw material situation at a particular point of time as well. So I just wanted to have...
Actually, if you look at the last 3, 4 years of our bottom line analysis, it's very clearly evident that the way the defence as well as international business is unfolding, it is helping us to increase our EBITDA margins. And before last 3, 4 years, we were continuously investing for creating infrastructure for defence, development of product. At the same time, we were expanding in new territories across the globe. So as a result, during those periods, the impact was there of higher overheads and higher depreciation, higher interest.
At the same time, we were facing losses due to foreign exchange fluctuations. So once we are coming out of those headwinds, so we are getting better EBITDA margins and as a result, better profit after tax also. So as far as volumes are concerned, definitely, sir, volumes are impacting or giving a positive support for the bottom line because the volumes which we are mentioning is only for Indian market. At the same time, in the international business, we are also expanding our volumes like I said. So it's a combination of these 2, 3 factors, which is helping us to deliver better results.
Right, which means, essentially, given the fact that defence is a rich margin or richer margin business in the international business also, I presume, is a richer profitability business. How they shape up, coupled with the volumes will really determine the amount of profits we make rather than looking at volumes in isolation. And volumes, as you correctly explained, is purely domestic and doesn't have impact from the other 2 activities.
True story. That is what the reality is.
Okay. Okay. And again, remarkable performance in a quarter which is seasonally otherwise not the best quarter, domestically speaking.
Correct, sir. Correct.
We have our next question from the line of Amit Dixit from ICICI Securities.
Congratulations for great performance, sir, and particularly the momentum on defence is very heartening. I have 2 questions on defence side only. So the first one is on that we have recently developed 3 new explosives, which were approved by Navy. So just wanted to get an update that what is happening on Air or Army? Where are we on that? And if there is any development on commercialization of these exposes as well as if you could highlight the further development in case of chaffs and -- chaff factory that whether we have sent any product for approval, the status over there?
Yes. Like we have shared in our previous quarters that we have developed the products like SEBEX and related products through our in-house R&D efforts, and those are definitely path-breaking products for our company's future growth. So like we have shared that these products are being tested by Navy and definitely going to add into the product list very soon.
But Amit, like you are aware that the qualifying the product, developing the product based on these raw materials, it takes time. So these are long-term initiatives, which will definitely deliver positive support for the company. And as far as the facility for chaff and flares are concerned, it is first of it's kind in India, which will be provisioning these products. So we have already participated in the RFPs, which require the products to be made in India, designed by Indian sources. So we are expecting the outcomes. So as we receive the orders, we will definitely share with all our stakeholders.
Okay. Sir, the second one is on Pinaka. While in the prepared remarks, you mentioned that we are expecting the order soon, but we have also certain media reports suggest that France is also showing interest in Pinaka. So once we get the domestic order, do we see significant export opportunities? Previously, I think they were kind of limited to, as we understand, to basically other friendly countries, but now with France coming and showing its interest, I think it becomes even more widespread. So just wanted to get your comments on that.
Yes. Like I have shared in my previous quarterly call that we are going to receive Pinaka order very soon. So very unfortunate that we have still not received the order. We were expecting orders to reach in our hand in the last month itself. But based on the Diwali vacation and long holiday season, so I think it got delayed due to all those reasons. And now we are expecting that in a month's time, we should receive, we should start getting Pinaka orders. So those will be definitely big milestone for our company.
Similarly, if you look at the -- apart from Indian opportunities, we all have seen the press articles, which shows that a lot of countries are showing interest in buying the products which is definitely a big achievement for Indian defence industry, Indian defence research organizations that countries like France are showing interest in buying these products. But definitely, as we move forward, there will be many such opportunities which can come up from friendly countries. So we are also looking forward for those opportunities. So whenever it will come, definitely, we will be there in the system or we will definitely get orders.
Sir, one more, if I can squeeze in again on defence. The DRDO has reached -- recently, we read certain articles that DRDO is kind of developing long-range rockets with guided rockets with an Indian company. So there could be a production order also for the same. So are we involved in this in some way or it is, I mean, too early to comment anything on this?
Definitely, we have also -- we are also aware that there are efforts in developing the longer range Pinaka rockets. So as such, it will be a bigger opportunity for a company like us to be participating in those programs. But since these programs are still in initial stages. So as we move forward, as we know, the things very clearly, we will keep you updated.
We have our next question from the line of Dipen Vakil from PhillipCapital.
Congratulations on a great execution quarter. Sir, my first question is in the line of -- in the order book, is it possible to give us a split between defence and nondefense?
Total order book stands at INR 5,757 crores. So out of that, defence stands at around INR 3,336 crores and around INR 2,224 crores is for explosives.
Noted, sir. Sir. And next question is, how has raw material prices mainly ammonium nitrate prices moved in last, say 1 year -- either year-on-year basis or quarter-on-quarter basis, if you can help us with the prices for those, please?
See, year-on-year basis, the raw material prices have been flat. So as you've see in our realization, it's around 2% fall. So raw material prices have fallen and currently, they have stabilized.
Sir, 1 last question. Sir, we have some new product development in the form of Bhargavastra. So -- and what stage would that be in right now? And are there trials or when will be the orders expected for that?
So we are developing this product from last couple of years. And we have also received some request for proposals where we have to share the specifications and we have to fine-tune those specifications based on the user requirements. So it is at that stage. But once RFP comes up, once we participate and once we receive the orders, we will share with you. But it is not going to be over in the next 6 months or 12 months. It may take 1 year or it may take 2 years also. We are definitely on the verge of developing and qualifying the products for armed forces requirements.
Got it, sir. Sir, the export orders that we have received in last month or so, most of them are explosive orders or a lot of them are equipment or production orders?
The orders details has already been shared. And if you look at those, then in the past 2 orders from international customers are for the defence products, and one of them was from India, which is Singareni Collieries.
Okay. So defence orders, so that's also export orders in defence-based application, are those from like product or explosives?
I didn't understand what you are asking actually.
No worries. I'll fall back on the queue and come back again.
We have our next question from the line of Pratik Mukasdar from RNL Investments.
Congratulations for a great set of numbers. And it is even heartening to see the guidance which you have given. I just want to ask, since you are dealing closely with the government every time and government spending in the last 6, 8 months due to election and all, and various other reasons is very slow. So as per your experience, what do you think about the government CapEx picking up? And secondly, is our EBITDA and PAT margin sustainable?
There are a couple of things like in every country, whenever there are elections. So definitely for a certain period of time, the decision-makers and bureaucracies are always involved and busy for those things. In India also, we have seen the similar thing because of election, a couple of months in this first half were getting slowed down because of those factors. If you look at the rainy season, which we all are aware of, this year, the country has seen record rainfall and normally it is above average by around 10%, which has impacted the mining and infrastructure activities.
But if you look at the India's growth projections and the government emphasis on housing and infrastructure. And if you look at the power demand, which was say, around 8% in the first half of the year. If you take out only 1 month of September, then definitely it is around 8%, which is a big rise in power consumption. So if you capture all these factors, so there can be seasonal up and down or 1 or 2 months of lag here or there. But on an overall basis, demand situation looks good to us.
And as far as the EBITDA margins are concerned, I have answered this question in just a couple of minutes back. Sir, as we are unfolding our capacities, as we are unlocking our defence verticals, so definitely, as a result of that, our EBITDA margin has increased. In last couple of years, we were seeing that EBITDA margin for our company, we were giving or sharing guidance of 20%, 22%, which has increased now 25% plus and in this quarter, we are seeing that it is 27% plus.
So if you look at all those things, definitely, it's an outcome of our efforts in the last many years of setting up infrastructure facilities and developing a variety of products, expanding ourselves in a variety of geographies. So as a result of all these efforts, we have seen better EBITDA margins. As far as sustainability of these margins in future is concerned, it is quite unreasonably optimistic on my part, if I say that we will achieve 30%, 20% every year. Definitely. It's a wish of every company that we should maintain all these margins. And we are reasonably optimistic that we should achieve 25% plus EBITDA margin going forward as well.
We have our next question from the line of Chirag Muchhala from Centrum Broking.
Sir, the question is on international markets. So in Q2, we have consolidated the South African entity, Problast. So sir, is it possible to share how much it is contributing sales?
In this quarter, the international business has delivered INR 799 crores revenue, and it includes all those subsidiaries.
Correct. But would Problast be very large as in kind of...
You will get the country-wise details at the annual results, which we will share after the end of this financial year.
Okay, sir. And directionally speaking, so a couple of large countries for us, which is Nigeria and Turkey. So how are their outlook for FY '25 considering that both of them have gone through individual country-specific problems last year? So in the H1, how was the demand? And how is the outlook for this year?
Yes. We have seen that in the last couple of years, we were struggling a lot in those new territories. But after taking a lot of corrective measures, we have seen a lot of improvements in South Africa and nearby countries and even in Australia also. So we are expecting and we have seen that those countries are showing a lot of positive turnaround. And as a result, performance has also improved and which has helped us in improving our margin also. So we believe that this momentum will continue.
Okay. And sir, for the Southeast Asian region, like Australia and Indonesia. So are both these countries' operations PAT positive now? And I mean what is our progress in terms of getting client approvals and revenue booking, et cetera?
Yes. We have set up the infrastructure. We got the licenses now, and we have started the operations. And now we are EBITDA positive in all those subsidiaries.
Okay. Okay. And sir, lastly, in terms of CapEx, as we have announced the CapEx from INR 800 crores to INR 1,200 crores. So 2 questions regarding that. Firstly, is it possible to give a breakup in terms of domestic market, overseas and defense for this INR 1,200 crores?
We will share at the end of the year, please.
Okay, sir. And a related question is that even in the next 1 to 2 years, will CapEx remain elevated like INR 1,000 crore plus kind of a figure will continue in FY '26, '27 as well?
As of now, like I said that in this year, we have revised our CapEx program from INR 800 crores to INR 1,200 crores. Looking at strong opportunities and a lot of orders in pipeline, we believe that there will be enough opportunities where we can invest more than INR 1,000 crores or INR 1,200 crores on an annualized basis. but it all depends how the things turn up, but we are optimistic. And we will share the CapEx program by end of this year, where we can give certain guidance on 1 year or 2 years CapEx programs. But as of now, like we said, we are targeting or we are -- the projects in pipeline will require around INR 1,200 crores of CapEx.
We have our next question from the line of Ravi Naredi from Naredi Investments.
Mr. Manish, you and your team deserve good accolades for nice result in H1 and since you took MD responsibility, sir, you have planned to increase CapEx and higher defence order, need high working capital. So how you plan fund for this?
So thank you very much for appreciating our efforts. As far as CapEx programs are concerned, we have opportunities, and we have revised our CapEx program to INR 1,200 crores. And most of this CapEx will be funded through our internal resources only. And we believe that by the end of this financial year, company should be debt-free with the optimism of defence orders and advances against them.
So nice, sir. Because so many companies make QIB. So if you are not making, it is a very wonderful thing for shareholders. Sir, INR 5,700 crores, we supply in how many years?
So INR 5,700 crores is the total order book and it includes explosives and defence also. And every order have different time lines. So by and large, all these -- some of them orders are for 2 years, some of them orders are for 3 years and a few of them are also 4 to 5 years. So it depends on each order. So it is difficult to give 1 average benchmark.
Sir, can we have the bifurcation of INR 5,700 crores order?
Yes, it is INR 2,400 crores from Coal India and Singareni and INR 3,300 crores approx from defence section.
We have a follow-up question from the line of Bharat Shah from ASK Investments.
Yes. Manish, our exports and international plus the defence in this quarter is almost about 2/3 of the total turnover, almost 66%. Would you say over, say, 3-year time frame, this percentage probably will move more like 75-25 or 80-20 because those seem to be the areas where greater trust overall also appears to be the -- resonate the faster growth.
Your observation is quite right, sir, and I definitely appreciate your analytics skill. So the point you have raised is very valid, sir. If you look at the Coal India, institutional and housing infra, which is basically Indian market for us, which is around, say, 1/3 of the total basket. And balance all is from our new initiatives in last, say, 10, 12 years, which was defence and international, which is now 2/3 of our business. As we move forward, I think defence verticals from Indian section will also go up and our international will keep doing around similar levels. But I think 2/3 percentage level is also a very high level and we believe it will continue like this. So 60% to 70% will come from these 2 new sections, and rest 30% will come from our core domestic businesses.
[Operator Instructions]
We have our next question from the line of Jenish Karia from Antique Stock Broking.
Sir, the question is on working capital side. There is a significant increase in the inventory and debtor days during the half year and reduction of the payable deals. So could you please help us understand where the working capital is getting blocked and is this permanent or just a one-off scenario because of muted domestic demand?
Yes, you're very correct with the last line that was muted domestic demand as Mr. Manishji has spoken that the rainfall had been quite high, and it was 8% above normal, and this was highest since 2020. So as a result, the inventory, you see the numbers in inventory and the working capital days from 84, it currently stands at 89, which is well within our normal business operations, 90.
And did Manish sir says that we will be net debt free by end of this year?
Yes, yes. Because we had mentioned that we'll be receiving different orders. And along with that, we'll have advances to -- considering those, we will be net debt positive by year-end.
Okay. So currently, the net debt stand at around INR 8 billion. Okay, you are including the current investments also.
[Operator Instructions] The next question is from the line of Narendra from Robo Capital.
Congratulations on a good set of numbers. My question is on the defence side. So given the strong order pipeline that we are looking at, would it be possible to give a kind of medium-term view on where we would like our defence segment to be in terms of revenue or order book in 2 or 3 years? Would it be possible, sir?
We have already given outlook on defence sales for this financial year, which is around INR 1,500 crores. We did around INR 500-odd crores in the last financial year. This year, we are expecting INR 1,500 crores. And once we receive all the orders or the orders from Pinaka and international business in next 1 or 2 quarters, we will be able to issue guidance for the next coming years.
Okay, sir. Okay. And on the 25% margin that you said, right, it's including the defence segment as well, right, on the consol basis you are expecting.
We say margins on overall basis, it includes explosives and defence also.
[Operator Instructions] The next question is from the line of [ Sehr Lakhani ] from -- an individual investor.
Manishji, my question was on the initiating systems part of our business, which I see is about INR 300 crores in H1 FY '25. Does there tend to be an attachment ratio between initiating systems and explosives because explosives, domestic explosives have grown by 12% in volume terms in H1 versus 2% volume growth in initiating systems?
Yes. So you are saying that, yes, we said that 12% volume growth is in explosive, but that doesn't run in proportionate. So initiating system, as you see a small part of revenue, so it stands at INR 304 crores out of INR 3,400 crores.
My question was on the disparity of growth because explosives was growing at 12% and initiating systems was growing at 2%. Is there an explanation for this?
I mean, that's not much of a correlation between those 2 because initiating system is a part which is needed along with the explosives.
Okay. And does the -- is the margin profile for initiating systems better than explosives?
Margins, as we said, we talk on overall business. So the current margin stands at 27.7% EBITDA margin, which includes both initiating system explosives, defence, everything.
Right. And we will be -- will it be possible to get some kind of guidance in terms of the capacity utilization for the initiative systems?
Capacity utilization for a business, which we are in, it's very difficult to speak on the capacity because every -- the different products of different capacities and utilization is not possible on a product-to-product basis. One single benchmark is not there because there are different SKUs.
So for the initiating systems, are we exporting this from India? Or is it also a part of the international business per se?
So it's a combination of both.
We have our next question from the line of Amit Dixit from ICICI Securities.
Again, I have actually 3 bookkeeping questions. The first one is on -- if I look at purchase of trading goods in the P&L statement that has gone up significantly high in this quarter. So just wanted to understand the nature of this and the trend, I mean, of this particular expense going ahead?
Yes. So you know that we have received the order of loitering munitions. So loitering munitions, the drones we have purchased from one of our associates that is Z Motion and then we have supplied that, after adding explosives to it, to the government.
Okay. Okay. Got it. Got it. So once this order is executed, this will return back to the original even provided we don't get further orders. Okay. Got this. The second one is on, if I look at receivables, they have also gone up while you have explained inventory increase in one of the earlier questions, why have receivables gone up? Is it due to increasing defence proportion and international operations? Or what is the reason for that? And whether this receivables also would be unlocked as we go ahead in H2?
Yes. If you see the international business has risen around 25% in this quarter -- 25% in this quarter. So obviously, the inventor -- debtor days, there are more as compared to the Indian sales. As a result, they have gone up.
Yes. And this is expected to be unlocked as we receive...
That will get reduced within the normal. As such, our normal working days are from 85 to 90, the total working capital cycle is there. But on a quarter-to-quarter basis, that may differ for some number of days.
Okay. But as the defence proportion and international business proportion increases, do you expect it to remain at elevated level or it will normalize at a certain point in time?
Currently, 80, 85 and 90, I said that it's a normalized level. So within that, [indiscernible] 4, 5 days may increase in a quarter. It depends on the sales when the sales are made.
Okay. The last one is that we actually recorded an expense. Of course, it's a noncash expense on the account of hyperinflationary accounting. So can you just explain a bit, it is around INR 18-odd crores for this quarter, INR 26 crores for H1, if I'm not mistaken. So I mean where do we see the hyperinflation in which -- about all countries and how is the situation in Q3 evolving?
So currently, the hyperinflationary economies are Ghana, Turkey and Zimbabwe where we operate. And this year, as compared to last year, we see the movement in these economies are not as high as compared to last year. But we have factored that in our cost. So we should see this should stabilize going forward.
Okay. Fair enough. And the last one is with South Africa, I mean, are we PAT positive over there?
Yes. Individually. On a stand-alone basis, also, we had been positive in last quarter itself. And this quarter also, we are positive.
Ladies and gentlemen, that would be the last question for today. And I now hand the conference over to Ms. Natasha Jain from Nirmal Bang Institutional Equities. Over to you, ma'am.
Thank you, once again, Manav, I would now request the management to give closing comments, if any.
Thank you so much, Natasha. We absolutely appreciate the time given by our well-wishers and shareholders, and we'll keep coming in the next quarter for these question and answer round from Mr. Manishji Nuwal. We expect our well-wishers to keep supporting us. Thank you so much.
Thank you, Aanchal. Now this concludes the conference. Participants can disconnect their lines. Thank you.
On behalf of Nirmal Bang Equities, that concludes this conference. Thank you for joining us, and you may now disconnect your lines.